Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects

Brain

Volumn 135, Issue 12, 2012, Pages 3627-3634

  Tzoulis, Charalampos ^a,b   Bindoff, Laurence A ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

MELAS; MSCAE; POLG; polymerase gamma; stroke

Indexed keywords

ACUTE MITOCHONDRIAL ENCEPHALOPATHY; ARTICLE; CEREBROVASCULAR ACCIDENT; DEATH; ENERGY METABOLISM; EPILEPSY; GENETIC DISORDER; HOMEOSTASIS; HUMAN; IMAGE ANALYSIS; ISCHEMIA; MITOCHONDRIAL ENCEPHALOPATHY; NERVE INJURY; NEUROIMAGING; NEURONAL ENERGY FAILURE; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY CHAIN; SYSTEMATIC REVIEW; TISSUE PERFUSION;

EID: 84871770632     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws223     Document Type: Article

References (87)

1. Ames A 3rd. CNS energy metabolism as related to function. Brain Res Brain Res Rev 2000; 34: 42-68.
2. Astrup J, Sorensen PM, Sorensen HR. Oxygen and glucose consumption related to Na+-K + transport in canine brain. Stroke 1981; 12: 726-30.
3. Bataillard M, Chatzoglou E, Rumbach L, Sternberg D, Tournade A, Laforet P, et al. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 2001; 56: 405-7.
4. Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006; 32: 359-73.
5. Bi WL, Baehring JM, Lesser RL. Evolution of brain imaging abnormalities in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol 2006; 26: 251-6.
6. Bottcher J, Kunze A, Kurrat C, Schmidt P, Hagemann G, Witte OW, et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 2005; 36: e20-2.
7. Canafoglia L, Franceschetti S, Antozzi C, Carrara F, Farina L, Granata T, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001; 56: 1340-6.
8. Chan DW, Lim CC, Tay SK, Choong CT, Phuah HK. Elevated thyroid peroxidase antibodies with encephalopathy in MELAS syndrome. Pediatr Neurol 2007; 36: 414-7.
9. Chou HF, Liang WC, Zhang Q, Goto Y, Jong YJ. Clinical and genetic features in a MELAS child with a 3271T4C mutation. Pediatr Neurol 2008; 38: 143-6.
10. Chuang YC, Chang AY, Lin JW, Hsu SP, Chan SH. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat. Epilepsia 2004; 45: 1202-9.
11. Chung SH, Chen SC, Chen WJ, Lee CC. Symmetric basal ganglia calcification in a 9-year-old child with MELAS. Neurology 2005; 65: E19.
12. Conforto AB, Yamamoto FI, Oba-Shinjo SM, Pinto JG, Hoshino M, Scaff M, et al. Screening for MELAS mutations in young patients with stroke of undetermined origin. Arq Neuropsiquiatr 2007; 65: 371-6.
13. Crimi M, Galbiati S, Moroni I, Bordoni A, Perini MP, Lamantea E, et al. A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome. Neurology 2003; 60: 1857-61.
14. Debray FG, Morin C, Janvier A, Villeneuve J, Maranda B, Laframboise R, et al. LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency. J Med Genet 2011; 48: 183-9.
15. de Coo IF, Sistermans EA, de Wijs IJ, Catsman-Berrevoets C, Busch HF, Scholte HR, et al. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes. Neurology 1998; 50: 293-5.
16. Deschauer M, Muller T, Wieser T, Schulte-Mattler W, Kornhuber M, Zierz S. Hearing impairment is common in various phenotypes of the mitochondrial DNA A3243G mutation. Arch Neurol 2001; 58: 1885-8.
17. DiMauro S, Hirano M. MELAS. GeneReviews at GeneTests: Medical Genetics Information Resource (database online). 1993. Copyright, University of Washington, Seattle 1997-2011. Available from: http://wwwgenetestsorg.
18. Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000; 529 (Pt 1): 57-68.
19. Engelsen BA, Tzoulis C, Karlsen B, Lillebo A, Laegreid LM, Aasly J, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 2008; 131 (Pt 3): 818-28.
20. Farrar MA, Lin CS, Krishnan AV, Park SB, Andrews PI, Kiernan MC. Acute, reversible axonal energy failure during stroke-like episodes in MELAS. Pediatrics 2010; 126: e734-9.
21. Feng F, You H, Gao J, Li XZ, Meng CL, Sun HY, et al. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J 2006; 21: 234-8.
22. Folbergrova J, Kunz WS. Mitochondrial dysfunction in epilepsy. Mitochondrion 2012; 12: 35-40.
23. Fornuskova D, Brantova O, Tesarova M, Stiburek L, Honzik T, Wenchich L, et al. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim Biophys Acta 2008; 1782: 317-25.
24. Glatz C, D'Aco K, Smith S, Sondheimer N. Mutation in the mitochondrial tRNA(Val) causes mitochondrial encephalopathy, lactic acidosis and stroke-like episodes. Mitochondrion 2011; 11: 615-9.
25. Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992; 42 (3 Pt 1): 545-50.
26. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyo-pathies. Nature 1990; 348: 651-3.
27. Gulyas AI, Buzsaki G, Freund TF, Hirase H. Populations of hippocampal inhibitory neurons express different levels of cytochrome c. Eur J Neurosci 2006; 23: 2581-94.
28. Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 2008; 17: 3822-35.
29. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005; 77: 430-41.
30. Hanna MG, Nelson IP, Morgan-Hughes JA, Wood NW. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosur PS 1998; 65: 512-7.
31. Hasuo K, Tamura S, Yasumori K, Uchino A, Goda S, Ishimoto S, et al. Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes); report of 3 cases. Neuroradiology 1987; 29: 393-7.
32. Herrero-Martin MD, Ayuso T, Tunon MT, Martin MA, Ruiz-Pesini E, Montoya J. A MELAS/MERRF phenotype associated with the mito-chondrial DNA 5521G4A mutation. J Neurol Neurosur PS 2010; 81: 471-2.
33. Hirano M, Pavlakis SG. Topical review: mitochondrial myopathy, enceph-alopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 1994; 9: 4-13.
34. Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscular Disord 1992; 2: 125-35.
35. Horvath R, Reilmann R, Holinski-Feder E, Ringelstein EB, Klopstock T. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G4A in ND1 of mtDNA. Neuromuscular Disord 2008; 18: 553-6.
36. Hsu YC, Yang FC, Perng CL, Tso AC, Wong LJ, Hsu CH. Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (melas) syndrome presenting as acute meningo-encephalitis: a case report. J Emerg Med 2009. Epub ahead of print.
37. Iizuka T, Sakai F, Ide T, Miyakawa S, Sato M, Yoshii S. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS-implication of neurovascular cellular mechanism. J Neurol Sci 2007; 257: 126-38.
38. Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003; 61: 1238-44.
39. Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002; 59: 816-24.
40. Ito H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev 2008; 30: 483-8.
41. Jaksch M, Kleinle S, Scharfe C, Klopstock T, Pongratz D, Muller-Hocker J, et al. Frequency of mitochondrial transfer RNA mutations and deletions in 225 patients presenting with respiratory chain deficiencies. J Med Genet 2001; 38: 665-73.
42. Jeppesen TD, Schwartz M, Hansen K, Danielsen ER, Wibrand F, Vissing J. Late onset of stroke-like episode associated with a 3256C-4T point mutation of mitochondrial DNA. J Neurol Sci 2003; 214: 17-20.
43. Karkare S, Merchant S, Solomon G, Engel M, Kosofsky B. MELAS with A3243G mutation presenting with occipital status epilepticus. J Child Neurol 2009; 24: 1564-7.
44. Kaufman KR, Zuber N, Rueda-Lara MA, Tobia A. MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review. Epilepsy Behav 2010; 18: 494-7.
45. Kim HS, Kim DI, Lee BI, Jeong EK, Choi C, Lee JD, et al. Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks. Yonsei Med J 2001; 42: 128-33.
46. Kim JH, Lim MK, Jeon TY, Rha JH, Eo H, Yoo SY, et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, enceph-alopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol 2011; 12: 15-24.
47. Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, et al. L-Arginine improves the symptoms of strokelike episodes in MELAS. 10.1212/01.WNL.0000151976.60624.01. Neurology 2005; 64: 710-2.
48. Kolb SJ, Costello F, Lee AG, White M, Wong S, Schwartz ED, et al. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 2003; 216: 11-5.
49. Kondo A, Saito Y, Seki A, Sugiura C, Maegaki Y, Nakayama Y, et al. Delayed neuropsychiatric syndrome in a child following carbon monoxide poisoning. Brain Dev 2007; 29: 174-7.
50. Kunz WS, Kudin AP, Vielhaber S, Blumcke I, Zuschratter W, Schramm J, et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000; 48: 766-73.
51. Lombes A, Mendell JR, Nakase H, Barohn RJ, Bonilla E, Zeviani M, et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol 1989; 26: 20-33.
52. Lonnqvist T, Paetau A, Valanne L, Pihko H. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009; 132 (Pt 6): 1553-62.
53. Malfatti E, Bugiani M, Invernizzi F, de Souza CF, Farina L, Carrara F, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain 2007; 130 (Pt 7): 1894-904.
54. Mena H, Cadavid D, Rushing EJ. Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol 2004; 108: 524-30.
55. Mizrachi IB, Gomez-Hassan D, Blaivas M, Trobe JD. Pitfalls in the diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol 2006; 26: 38-43.
56. Nakamura M, Nakano S, Goto Y, Ozawa M, Nagahama Y, Fukuyama H, et al. A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 1995; 214: 86-93.
57. Nishioka J, Akita Y, Yatsuga S, Katayama K, Matsuishi T, Ishibashi M, et al. Inappropriate intracranial hemodynamics in the natural course of MELAS. Brain Dev 2008; 30: 100-5.
58. Ohama E, Ohara S, Ikuta F, Tanmaka K, Nishiwaza M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathologica 1987; 74: 226-33.
59. Ohshita T, Oka M, Imon Y, Watanabe C, Katayama S, Yamaguchi S, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000; 42: 651-6.
60. Ooiwa Y, Uematsu Y, Terada T, Nakai K, Itakura T, Komai N, et al. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke 1993; 24: 304-9.
61. Oppenheim C, Galanaud D, Samson Y, Sahel M, Dormont D, Wechsler B, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000; 69: 248-50.
62. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
63. Rachinger J, Fellner FA, Stieglbauer K, Trenkler J. MR changes after acute cyanide intoxication. AJNR Am J Neuroradiol 2002; 23: 1398-401.
64. Rahman S. Mitochondrial disease and epilepsy. Dev Med Child Neurol 2012; 54: 397-406.
65. Riudavets MA, Aronica-Pollak P, Troncoso JC. Pseudolaminar necrosis in cyanide intoxication: a neuropathology case report. Am J Forensic Med Pathol 2005; 26: 189-91.
66. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217: 331-45.
67. Schomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia 1993; 34 (Suppl 1): S29-36.
68. Serra G, Piccinnu R, Tondi M, Muntoni F, Zeviani M, Mastropaolo C. Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap. Brain Dev 1996; 18: 185-91.
69. Siskas N, Lefkopoulos A, Ioannidis I, Charitandi A, Dimitriadis AS. Cortical laminar necrosis in brain infarcts: serial MRI. Neuroradiology 2003; 45: 283-8.
70. Stoquart-Elsankari S, Lehmann P, Perin B, Gondry-Jouet C, Godefroy O. MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS. J Neurol 2008; 255: 1593-5.
71. Takahashi S, Tohgi H, Yonezawa H, Obara S, Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 1998; 158: 58-64.
72. Tanji K, Gamez J, Cervera C, Mearin F, Ortega A, de la Torre J, et al. The A8344G mutation in mitochondrial DNA associated with stroke-like episodes and gastrointestinal dysfunction. Acta Neuropathol 2003; 105: 69-75.
73. Trevelyan AJ, Kirby DM, Smulders-Srinivasan TK, Nooteboom M, Acin-Perez R, Enriquez JA, et al. Mitochondrial DNA mutations affect calcium handling in differentiated neurons. Brain 2010; 133 (Pt 3): 787-96.
74. Tsujikawa T, Yoneda M, Shimizu Y, Uematsu H, Toyooka M, Ikawa M, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2010; 32: 143-9.
75. Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke 2009; 40: e15-7.
76. Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006; 129: 1685-92.
77. Tzoulis C, Neckelmann G, Mork SJ, Engelsen BE, Viscomi C, Moen G, et al. Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain 2010; 133 (Pt 5): 1428-37.
78. Uemura K, Harada K, Sadamitsu D, Tsuruta R, Takahashi M, Aki T, et al. Apoptotic and necrotic brain lesions in a fatal case of carbon monoxide poisoning. Forensic Sci Int 2001; 116: 213-9.
79. Wang XY, Noguchi K, Takashima S, Hayashi N, Ogawa S, Seto H. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology 2003; 45: 640-3.
80. Wang Z, Qi XK, Yao S, Chen B, Luan X, Zhang W, et al. Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G4A mutation, and neuropathological findings in one autopsy case. Neuropathology 2010; 30: 606-14.
81. Watanabe Y, Hashikawa K, Moriwaki H, Oku N, Seike Y, Kodaka R, et al. SPECT findings in mitochondrial encephalomyopathy. J Nucl Med 1998; 39: 961-4.
82. Winterthun S, Ferrari G, He L, Taylor RW, Zeviani M, Turnbull DM, et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochon-drial polymerase {gamma} mutations. Neurology 2005; 64: 1204-8.
83. Yamashita S, Nishino I, Nonaka I, Goto Y. Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions. J Hum Genet 2008; 53: 598-606.
84. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, KuriyaMayka M.A. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999; 53: 2182-4.
85. Yoneda Y, Yamamoto S. Cerebral cortical laminar necrosis on diffusion-weighted MRI in hypoglycaemic encephalopathy. Diabet Med 2005; 22: 1098-100.
86. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 2001; 22: 269-72.
87. Zeviani M, Muntoni F, Savarese N, Serra G, Tiranti V, Carrara F, et al. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene [published erratum appears in Eur J Hum Genet 1993; 1(2):124]. Eur J Hum Genet 1993; 1: 80-7.